Highnoon Laboratories Limited (PSX:HINOON)
Pakistan · Delayed Price · Currency is PKR 1,171.12
+10.97 (0.95%)
At close: Sep 3, 2025
Highnoon Laboratories Revenue
Highnoon Laboratories had revenue of 6.16B PKR in the quarter ending June 30, 2025, with 4.45% growth. This brings the company's revenue in the last twelve months to 25.78B, up 17.75% year-over-year. In the year 2024, Highnoon Laboratories had annual revenue of 24.63B with 24.60% growth.
Revenue (ttm)
25.78B
Revenue Growth
+17.75%
P/S Ratio
2.42
Revenue / Employee
10.85M
Employees
2,376
Market Cap
62.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 24.63B | 4.86B | 24.60% |
| Dec 31, 2023 | 19.77B | 3.95B | 24.98% |
| Dec 31, 2022 | 15.82B | 2.82B | 21.65% |
| Dec 31, 2021 | 13.00B | 2.30B | 21.53% |
| Dec 31, 2020 | 10.70B | 1.65B | 18.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GlaxoSmithKline Pakistan | 62.62B |
| Abbott Laboratories (Pakistan) | 72.39B |
| The Searle Company | 29.12B |
| AGP Limited | 26.11B |
| Shifa International Hospitals | 26.63B |
| Citi Pharma | 12.97B |
| Ferozsons Laboratories | 18.16B |
| Macter International | 8.48B |